Reported figures and Equlion model projections for the next 5 years.
Metric
2025 (actual)
2026 (forecast)
2027
2028
2029
2030
2031
Trend
ROE
-4.03%
-4.81%
-4.33%
-5.15%
-6.33%
-7.49%
-8.71%
ROA
-3.92%
-4.68%
-4.2%
-4.98%
-6.08%
-7.13%
-8.23%
Gross Margin
56.73%
61.23%
61.23%
61.23%
61.23%
61.23%
61.23%
Sector average
-
17.71%
17.71%
17.71%
17.71%
17.71%
62.35%
Net Margin
-201.18%
Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for Moberg Pharma AB (publ)? It covers the balance sheet, income statement and Equlion model projections.
-156.26%
-121.88%
-123.7%
-125.49%
-126.54%
-127.25%
Total Assets
SEK 682,264.00K
SEK 681,393.00K
SEK 655,450.21K
SEK 625,798.13K
SEK 591,837.17K
SEK 553,268.29K
SEK 511,220.62K
Sector average
-
SEK 2,900,240.60K
SEK 3,045,009.79K
SEK 3,280,286.42K
SEK 3,536,407.14K
SEK 3,762,908.71K
SEK 1,806,991.80K
Net Income
-SEK 27,236.00K
-SEK 31,918.07K
-SEK 28,098.05K
-SEK 31,882.45K
-SEK 37,017.77K
-SEK 40,851.42K
-SEK 43,805.71K
Sector average
-
-SEK 22,027.28K
-SEK 904.69K
-SEK 7,253.84K
-SEK 3,858.45K
-SEK 1,547.00K
-SEK 13,704.11K
Valuation
-
SEK 484,546.57K
SEK 426,555.04K
SEK 484,005.78K
SEK 561,964.79K
SEK 620,163.33K
SEK 665,012.24K
Sector average
-
SEK 5,151,301.60K
SEK 5,189,236.02K
SEK 5,317,343.69K
SEK 5,514,329.75K
SEK 5,636,782.17K
SEK 3,179,755.44K
Stock Price
-
SEK 10.27
SEK 9.04
SEK 10.26
SEK 11.91
SEK 13.14
SEK 14.09
Sector average
-
SEK 48.04
SEK 48.69
SEK 50.45
SEK 52.13
SEK 53.41
SEK 36.70
Moberg Pharma AB (publ) (MOB.ST) Financial Forecast | Equlion
